Results 131 to 140 of about 3,978,530 (165)

Cost-Effectiveness of Psilocybin-Assisted Therapy for Severe Depression: Exploratory Findings From a Decision Analytic Model [PDF]

open access: yesPsychological Medicine, 2023
Background There is growing evidence to support the use of the psychedelic drug psilocybin for difficult-to-treat depression. This paper compares the cost-effectiveness of psilocybin assisted psychotherapy (PAP) with conventional medication, cognitive ...
Paul McCrone, David Nutt, Jo C. Neill
exaly   +3 more sources

Exploring the Credibility of Psilocybin-Assisted Therapy and Cognitive-Behavioral Therapy for Depression

Journal of Psychoactive Drugs, 2022
Depression treatments succeed with many but leave others unimproved, and they can generate concerns about side effects, time, and cost. Psilocybin has generated media attention and empirical support for antidepressant effects, but lay impressions of its effectiveness are unclear.
Brianna Altman   +2 more
exaly   +3 more sources

Psilocybin-assisted therapy for depression: A systematic review and meta-analysis

Psychiatry Research, 2023
The aim of this review was to determine the effect of psilocybin on depressive symptoms in patients diagnosed with life-threatening illnesses or major depressive disorder. Systematic searches were conducted to search for randomized clinical trials and open-label trials that evaluated depression symptoms after psilocybin therapy. Data was pooled using a
Sipan Haikazian   +8 more
openaire   +2 more sources

Psychotherapists' Openness to Engage Their Patients in Psilocybin-Assisted Therapy for Mental Health Treatment

Journal of Affective Disorders, 2023
Despite psychedelic research initially ceasing in the 1970-80s, the findings documented encouraged researchers to re-examine the safety and efficacy of treating mental health with psychedelics. Of particular focus, psilocybin has shown to have therapeutic potential for a variety of mental health problems and was granted breakthrough therapy status by ...
Jair C Soares   +2 more
exaly   +3 more sources

Psilocybin‐assisted group therapy in patients with cancer diagnosed with a major depressive disorder

Cancer, 2023
AbstractBackgroundDepression is common in patients with cancer and is associated with lower treatment adherence and reduced quality of life. Antidepressants and psychotherapy have limited success in improving depression among patients with cancer. This study explored the safety, feasibility, and efficacy of psilocybin‐assisted therapy in patients with ...
Manish Agrawal   +12 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy